A US appeals court on Monday invalidated Acorda Therapeutics Inc patents covering its multiple sclerosis drug Ampyra, opening the door to generic ... read more
US appeals court invalidates Acorda patents on MS drug
US appeals court invalidates Acorda patents on MS drug